← Leaderboards
Richard Groen
Dana-Farber Cancer Inst
$821,444
Attributed
$1,642,887
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $563K · FY2016–18$1M$750K$500K$250K$0
'16
'17
'18
Funding mix
By agency
NIH$1,642,887 · 1
By mechanism
R01$1,642,887 · 1
Top collaborators
- Constantine S. Mitsiades3 shared
Most similar at Dana-Farber Cancer Inst
Same institution · by research overlap
- Wilfred Ngwa$5,702,695
- Steven P. Balk$19,509,335
- David Marc Weinstock$10,844,261
- Mark M. Pomerantz$1,781,713
- Alexander H. Stegh$12,620,634
Others in their field
Top investigators on “Collection”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$574,712,442
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David R. Weir · University Of Michigan At Ann Arbor$414,261,438
- David Heimbrook · Leidos Biomedical Research, Inc.$349,689,844
- Marian Ewell · The Emmes Company, Llc$276,352,498
Research focus
CollectionConventional TherapyAnticancer ResearchCohortAcute LeukemiaBaseB-Cell Acute LeukemiaBehaviorArchitectureAftercareAutologousBoneBone MarrowCancer CellCandidate MarkerCd34 GeneCell ProliferationCellsCeramicsChronic LeukemiaClinically RelevantBiological PreservationClinical TreatmentDiagnosis
Grant awards (3)
Humanized bone marrow-like model to study patient-derived myeloma xenografts$537,912
R01 · FY2018 · CA
Humanized bone marrow-like model to study patient-derived myeloma xenografts$541,945
R01 · FY2017 · CA
Humanized bone marrow-like model to study patient-derived myeloma xenografts$563,030
R01 · FY2016 · CA